A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
Clinical trial NCT03989232 · COMPLETED
Trial details
- NCT number
- NCT03989232
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2020-09-18
- Enrollment
- 961
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.